Pubblicazioni Scientifiche
Dermatologia29 nov 2021
Updates in cutaneous manifestations of systemic vasculitis
The main purpose of this review is to present newly reported cutaneous manifestations of systemic vasculitis, updates in investigations to verify systemic involvement in cases with cutaneous vasculitis and new therapeutic guidelines
29 nov 2021
Comparison between Kimura’s disease and angiolymphoid hyperplasia with eosinophilia
Kimura's disease (KD) is a rare chronic inflammatory or allergic disease. Angiolymphoid hyperplasia with eosinophilia (ALHE) is a benign vascular neoplasm.
29 nov 2021
Photoprotection according to skin phototype and dermatoses
Increasing evidence on the impact of the different wavelengths of sunlight on the skin demonstrates the need for tailored recommendations of sunscreen according to skin phototype and dermatoses, which is now possible due to advances in the filters and formulations of sunscreens.
22 nov 2021
Risk of vulvar squamous cell carcinoma in lichen sclerosus and lichen planus
The objectives of this study were to determine: 1) the prevalence of lichen sclerosus (LS) and lichen planus (LP) present in association with vulvar squamous cell carcinoma (VSCC), and 2) the incidence and absolute risk of developing VSCC in LS and LP.
22 nov 2021
Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis
Psoriasis is a multifactorial immune-mediated disease.
22 nov 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors
Atopic dermatitis is a chronic, relapsing and remitting disease that can be difficult to treat despite a recently approved biologic therapy targeting IL-4/IL-13 receptor.
15 nov 2021
The burden of psoriasis on patient's caregivers
The burden of psoriasis on patient's caregivers
15 nov 2021
Body Mass Index and Melanoma Prognosis
Obesity has been suggested as a risk factor in the progression of malignancies, including melanoma.
15 nov 2021
Review BRAF inhibition and the spectrum of granulomatous reactions
BRAF-inhibitors have emerged as a promising targeted therapy for malignancies with BRAF mutations, particularly metastatic melanoma
15 nov 2021
Efficacy of a tailored moisturizer for reducing chemotherapy-induced
Efficacy of a tailored moisturizer for reducing chemotherapy-induced skin dryness in breast cancer patients
08 nov 2021
Pruritus and prurigo
Pruritus and prurigo: a significant advancement on diagnosis, classification, pathogenesis and treatment
08 nov 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome Part II
Primary cutaneous T-cell lymphomas (CTCLs) other than mycosis fungoides (MF) and Sézary syndrome (SS) encompass a heterogenous group of non-Hodgkin lymphomas
08 nov 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome Part I
Primary cutaneous T-cell lymphomas (CTCLs) are defined as lymphomas with a T-cell phenotype that present in the skin without evidence of systemic or extracutaneous disease at initial presentation
01 nov 2021
Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin
The association between isotretinoin and psychiatric disturbance, including depression and suicidal behavior, is controversial.
01 nov 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
Cutaneous squamous cell carcinoma (cSCC) has an overall favourable outcome, except for patients with an advanced stage disease.
01 nov 2021
Dermoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas
Limited data on dermoscopy of nodular/plaque-type T/B-cell primary cutaneous lymphomas (PCLs) is available.
19 ott 2021
Treatment challenges in clinically amyopathic dermatomyositis
The term clinically amyopathic dermatomyositis (CADM) is used to represent a subgroup of patients
19 ott 2021
Dermatological Manifestations in Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBDs) may be associated with extra-intestinal manifestations.
19 ott 2021
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compared in clinical trials.
11 ott 2021
Phase 2a randomized clinical trial of dupilumab
Treatments for alopecia areata (AA) patients with extensive scalp hair loss are limited